In the tumor microenvironment, B7-H3 inhibits CD4+ and CD8+ T cell responses by inhibiting IFN-γ, IL2, IL-10 and IL-13 (160) and promotes the immune escape of tumor cells (161, 162). Here, CD276 is linked to neoplasm.